Morphinans

Results: 6441



#Item
41ATION ASSISTED TREATMENT• BUPRENORPHINE• NALTREXONE• MEDICATION ASSISTED TREATMENT• BUPRENORPHINE• NALTREXONE• MED  SISTED TREATMENT• BUPRENORPHINE• NALTREXONE• MEDICATION ASSISTED TREATMENT• BUPRENOR

ATION ASSISTED TREATMENT• BUPRENORPHINE• NALTREXONE• MEDICATION ASSISTED TREATMENT• BUPRENORPHINE• NALTREXONE• MED SISTED TREATMENT• BUPRENORPHINE• NALTREXONE• MEDICATION ASSISTED TREATMENT• BUPRENOR

Add to Reading List

Source URL: www.dhhs.nh.gov

Language: English - Date: 2016-03-16 14:13:24
42Portfolio Drug Substance List Products Therapeutic Areas  Available Grades

Portfolio Drug Substance List Products Therapeutic Areas Available Grades

Add to Reading List

Source URL: www.siegfried.ch

Language: English - Date: 2016-06-17 08:07:48
43Chronic Opioid Management Report

Chronic Opioid Management Report

Add to Reading List

Source URL: www.pinnacol.com

Language: English - Date: 2010-06-16 14:11:34
44Medication Guide For A Safe Recovery  A guide to maintaining sobriety while receiving treatment for other health problems.

Medication Guide For A Safe Recovery A guide to maintaining sobriety while receiving treatment for other health problems.

Add to Reading List

Source URL: www.dopl.utah.gov

Language: English - Date: 2013-11-19 10:37:21
45Atlantic Pharmaceuticals, Inc. Announces Third Patent Issuance on SMART/Script ™ Abuse Deterrent Drug Delivery System August, 20thAtlantic Pharmaceuticals, Inc., today announced that the United States Patent and

Atlantic Pharmaceuticals, Inc. Announces Third Patent Issuance on SMART/Script ™ Abuse Deterrent Drug Delivery System August, 20thAtlantic Pharmaceuticals, Inc., today announced that the United States Patent and

Add to Reading List

Source URL: www.atlanticpharma.com

Language: English - Date: 2013-10-30 13:18:20
46Table 18 A list of approved items innew drugs) Category 1  Date of

Table 18 A list of approved items innew drugs) Category 1 Date of

Add to Reading List

Source URL: www.pmda.go.jp

Language: English - Date: 2016-08-02 03:30:14
47HIGHLIGHTS OF PRESCRIBING INFORMATION  • Do not abruptly discontinue BELBUCA in a physically dependent patient. These highlights do not include all the information needed to use BELBUCA safely and effectively. See full

HIGHLIGHTS OF PRESCRIBING INFORMATION • Do not abruptly discontinue BELBUCA in a physically dependent patient. These highlights do not include all the information needed to use BELBUCA safely and effectively. See full

Add to Reading List

Source URL: www.endo.com

Language: English - Date: 2015-12-08 07:37:32
48Microsoft Word - NARCAN Approval Press Release FINAL

Microsoft Word - NARCAN Approval Press Release FINAL

Add to Reading List

Source URL: preview.thenewsmarket.com

Language: English - Date: 2016-01-21 15:24:28
49OPIOIDS IN AMERICA  A complex crisis. A comprehensive response. There’s only one way to successfully handle a situation this complex: with a coordinated response from every angle.

OPIOIDS IN AMERICA A complex crisis. A comprehensive response. There’s only one way to successfully handle a situation this complex: with a coordinated response from every angle.

Add to Reading List

Source URL: www.rti.org

Language: English - Date: 2016-08-20 11:33:02
50Preferred Drug List Effective June 1, 2016 Blue Cross Complete participates in the Michigan Common Formulary PH-06/Rev06

Preferred Drug List Effective June 1, 2016 Blue Cross Complete participates in the Michigan Common Formulary PH-06/Rev06

Add to Reading List

Source URL: mibluecrosscomplete.com

Language: English - Date: 2016-08-02 16:49:02